Reimagining Cancer Treatment with Superior Targeted Radiotherapy
Our technology combines 211-Astatine, the most druggable alpha-emitting radioisotope, with our proprietary Radiobody™ targeting molecules. This innovative approach ensures precise radiation delivery, destroying tumor cells by breaking their DNA strands without harming surrounding healthy cells.
Welcome to the future of cancer treatment
Our innovative approach tackles the challenges of cancer treatment by harnessing the power of radiation and targeted delivery using multivalent single-domain antibodies.
We aim to deliver more effective treatment options while minimizing side effects and improving patient outcomes.